Sleep Coach for Adolescents With Type 1 Diabetes
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Sleep Coach, Diabetes Education.
- Who it may be relevant to
- Registry conditions: Type 1 Diabetes. Basic parameters: 11 years — 17 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Sleep Promoting Intervention to Improve Diabetes Outcomes and Executive Function in Adolescents With T1D
Overview
The goal of this work is to conduct a randomized trial evaluating the effects of a behavioral intervention to increase sleep duration and quality for adolescents with type 1 diabetes (T1D). The impact of the sleep-promoting intervention on executive function and glycemic outcomes will be assessed. We will also explore multiple components of the recently identified central nervous system glymphatic system and evaluate how these components change and impact brain integrity and function with improved sleep.
Detailed description
This randomized controlled trial will assess whether a behavioral coaching intervention to improve sleep duration and quality in adolescents with type 1 diabetes will improve glucose control and executive function. We will recruit a sample of 150 adolescents with type 1 diabetes (T1D) and their caregivers at a single medical center. We plan to recruit equal numbers of boys and girls and over-enroll youth from minoritized racial and ethnic groups. After obtaining informed consent/assent and baseline data, we will randomize adolescents to the Sleep Coach condition (n=75) or the Enhanced Usual Care condition (n=75). Randomization will be computerized, and adolescents will be stratified by diabetes device use (insulin pumps, continuous glucose monitors) and age (11-14 years vs. 15-17 years). Adolescents and caregivers will complete survey measures again at 3 months, 6 months, and 12 months during regularly scheduled clinic visits. Adolescents will complete the NIH Toolbox measures of executive function at each study visit. Adolescents will be asked to wear a FitBit watch to assess sleep and complete sleep diaries at baseline and 3 months.
Participants randomized to the Sleep Coach group will be sent a binder with intervention materials for the 4 sessions. They will schedule individual phone calls with a trained member of the research team at a convenient time. The first call is expected to last 20-30 minutes, and the other calls are expected to last 10-15 minutes. Caregivers will receive an overview of the sleep intervention content, and they will be asked to support adolescents' attempts to change sleep habits.
Adolescents randomized to Enhanced Usual Care will receive diabetes education materials developed by our team for adolescents with T1D (based on publicly available materials on diabetes.org). Printed materials will be sent via mail and content will be shared via smart phone messages on the same schedule as participants randomized to the Sleep Coach intervention.
A representative group of 50 of the 150 adolescents in the study will be invited to participate in an additional study visit prior to the intervention to obtain magnetic resonance imaging (MRI) of the brain. Adolescents who agree to complete MRI of the brain will be asked to complete a follow-up visit approximately 6 months after the baseline visit, following the same protocol, and they will complete the daily sleep diary questions and share sleep data for another week.
Interventions
- Behavioral Sleep Coach
Sleep-promoting intervention consisting of 4 phone sessions to improve sleep duration and consistency. - Behavioral Diabetes Education
Participants will receive a a binder with educational information about diabetes and educational messages from the study team.
Primary outcome measures
- Sleep Duration [Time frame: 3 months]
- Sleep Variability [Time frame: 3 months]
Secondary outcome measures (10)
- Executive Function BRIEF2 [Time frame: 12 months]
- NIH Toolbox Dimensional Card Sort Test [Time frame: 12 months]
- NIH Toolbox List Sorting Working Memory Test [Time frame: 12 months]
- Diabetes Management - Adolescent Report [Time frame: 12 months]
- Diabetes Management - Parent Report [Time frame: 12 months]
- Sleep Quality [Time frame: 12 months]
- Hemoglobin A1C [Time frame: 12 months]
- Time in Range [Time frame: 12 months]
- Magnetic Resonance Imaging (MRI) of Brain: Glymphatic Flow [Time frame: 6 months]
- Fractional Anisotropy from MRI of the Brain [Time frame: 6 months]
Eligibility criteria
Inclusion criteria
- 11-17 years of age at the time of enrollment
- Diagnosed with type 1 diabetes for ≥ 12 months
- Report insufficient sleep (< 8 hrs./night for 13-17 year-olds, <9 hrs./night for 11-12 year-olds) but have no other sleep disorders or sleep apnea
- Are not meeting the target for HbA1c (<7%)
- Able to read /speak English
Exclusion criteria
- Participant has other serious health conditions that interfere with diabetes management
- Optional MRI portion of the study - anything that would prevent an adolescent from receiving a high-quality MRI of the brain (metal implants or inability to hold still for an MRI which may take up to 60 minutes)
Inclusion criteria for caregivers:
- Currently living with the child (at least 50% of the time)
- Speak and read English
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Treatment
Study locations
United States · 1 center
- Vanderbilt University Medical Center — Nashville
Identifiers
NCT: NCT06516614 · 230074